跳至主要内容
临床试验/NL-OMON37030
NL-OMON37030已完成不适用

Experimental Human Rhinovirus Infection, a randomized placebo-controlled pilot study - EHRVI

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Written informed consent
  • - Age >=18 and <=35
  • - Use of contraceptives (for female subjects only)

排除标准

  • - Pregnancy or lactating
  • - Pre-existent lung disease, including asthma
  • - A history of allergic rhinitis with positive allergen skin tests
  • - Use of any medication
  • - Use of alcohol > 5/day or >20/wk
  • - Use of any drugs
  • - Current smoker or more than 5 pack-year history
  • - Frequently have nosebleeds
  • - Recent nasal or otologic surgery
  • - Febrile illness or a common cold within four weeks before the HRV challenge
  • - Currently participating in another clinical trial
  • - Use of antibiotics, norit, laxatives (up till 6 months prior to inclusion), cholestyramine, acid burn inhibitors or immune suppressive agents (up till 3 months prior to inclusion), and pre- and probiotics (up till 1 month prior to inclusion).

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验